Fast, lightweight BBB permeability predictions for molecular design
Year: 2026
Type: article
Abstract: The blood-brain barrier (BBB) is a selectively permeable border that regulates the transport of chemical compounds into and out of the central nervous system (CNS). To discover medicinal drugs that can target the CNS, we must be able to efficiently screen pools of potential candidate CNS-targeting drugs to identify those that can permeate the BBB. However, drugs that readily permeate the BBB are comparatively rare, thus CNS drug discovery typically requires screening very large candidate libraries. In the last two decades, a diverse portfolio of machine learning models has been developed to predict the permeability of the BBB. However, many of the most accurate models reported to date do not scale well to large screenings, because they depend on high-cost descriptor pipelines and/or computationally intensive model architectures. In this work, we used a straightforward, computationally efficient set of descriptors in conjunction with a lightweight random forest model to perform a large-scale screening for BBB permeable drugs. Specifically, we predicted the propensity to cross the BBB for roughly 117 million compounds from PubChem. The screen ran on CPU-only hardware (64 cores) and completed in less than 800 CPU hours; the main resource constraint was memory, with ∼4 TB RAM required for data handling. From these predictions, we prioritised a small set of top-ranked compounds and used well-tempered metadynamics with lipid-bilayer proxies to assess whether their membrane-crossing barriers were consistent with the model-predicted permeability classes. We hope that similar workflows can be adopted in the near term to improve the throughput of BBB-permeability prioritisation in drug discovery.
DOI: 10.1039/d6me00041j
Authors: Hengjian Jia, Gabriele Cesare Sosso
Institution: University of Warwick
Language: English
Subfield: Drug Discovery
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W7225191809
